Rapid Antigen Testing for SARS-CoV-2 Detection
Summary
Rapid antigen testing has emerged as a crucial pillar in the global response to the COVID-19 pandemic, offering a rapid, cost-effective, and decentralised means of detecting active SARS-CoV-2 infections. Unlike laboratory-based molecular assays, these tests employ immunochromatographic methods to identify viral nucleocapsid protein directly from upper respiratory samples, providing results typically within 15–30 minutes. Their portability and ease of use have enabled widespread deployment in community settings, workplaces, educational institutions and points of entry, facilitating early identification of infectious individuals and rapid public health interventions. Technological refinements have improved analytical sensitivity and specificity, while operational factors such as specimen type, time since symptom onset and viral load dynamics influence performance. As variants of concern have arisen, real-world evaluations have demonstrated that many rapid antigen tests maintain the capacity to detect infections across successive waves, albeit with reduced sensitivity in asymptomatic cases and at lower viral loads. By balancing pragmatic access with acceptable diagnostic accuracy, rapid antigen testing supports frequent surveillance, outbreak containment and strategic resource allocation, particularly where laboratory infrastructure is limited.
Research from Nature Portfolio
No recent Nature Portfolio content available.
Rapid Antigen Testing for SARS-CoV-2 Detection publication trend
The graph below shows the total number of articles in rapid antigen testing for sars-cov-2 detection across all publications each year (not limited to Nature Index journals).
Technical terms
Rapid antigen test: An immunoassay that detects SARS-CoV-2 viral proteins directly from clinical samples for rapid diagnosis.
Lateral flow device: A paper-based diagnostic strip employing antibodies to capture and visualise viral antigens without laboratory equipment.
Sensitivity: The proportion of infected individuals correctly identified as positive by a diagnostic test.
Specificity: The proportion of uninfected individuals correctly identified as negative by a diagnostic test.
Cycle threshold (Ct): The number of amplification cycles in RT-PCR required to detect viral RNA, inversely related to viral load.
References
- Performance of antigen lateral flow devices in the UK during the alpha, delta, and omicron waves of the SARS-CoV-2 pandemic: a diagnostic and observational study. The Lancet Infectious Diseases (2023).
- Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis. PLOS Medicine (2021).
- Comparison of seven commercial SARS-CoV-2 rapid point-of-care antigen tests: a single-centre laboratory evaluation study. The Lancet Microbe (2021).
About these summaries
This Nature Research Intelligence Topic summary is created with the cited references and a large language model. We take care to ground generated text with facts, and have systems in place to gain human feedback on the overall quality of the process in line with our AI principles. We strive to create accurate and useful summaries for people unfamiliar with the research topic and that supports this goal. These pages are a beta release and will be updated as we learn how best to help people gain value from a research topic summary.
Turn complex research questions into confident strategic decisions
When you're under pressure to set direction, justify investment, or understand your competitive position, you need more than raw data — you need trusted insights you can act on.
Benchmark your performance against global peers using robust, methodologically sound analysis.
Combine quantitative metrics with qualitative expert insight to uncover strengths, gaps and emerging opportunities.
Gain tailored, decision-ready recommendations aligned to your strategic priorities.
Talk to us to learn more about our data dashboards and bespoke strategy reports.
Grow research skills, confidence and careers with training built for every stage of the research lifecycle.
Developed with Nature Portfolio journal Editors and internationally renowned experts. Discover three ways to learn:
Self-paced, online courses in convenient bite-sized units, covering key skills across scientific writing, publishing, grant writing, data analysis, and more.
Expert trainer-led workshops with hands-on exercises and real-time feedback across core research skills, delivered via interactive group sessions.
Editor-led workshops combining core principles in writing and publishing, personalised 1:1 feedback from Nature Portfolio Editors and hands-on exercises.
Explore course catalogues and workshop agendas, enquire about the options or request institutional pricing.